Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 1998, p. 257-262, Vol. 42, No. 2
Antimicrobial Research
Laboratory1 and the
Mycobacterial
Reference Laboratory,
Received 14 May 1997/Returned for modification 7 August
1997/Accepted 11 November 1997
Erythromycin resistance among streptococci is commonly due to
target site modification by an rRNA-methylating enzyme, which results in coresistance to macrolide, lincosamide, and streptogramin B
antibiotics (MLSB resistance). Genes belonging to the
ermAM (ermB) gene class are the only
erythromycin resistance methylase (erm) genes in
Streptococcus pyogenes with MLSB resistance
that have been sequenced so far. We identified a novel
erm gene, designated ermTR, from an
erythromycin-resistant clinical strain of S. pyogenes (strain A200) with an inducible type of MLSB
resistance. The nucleotide sequence of ermTR is 82.5%
identical to ermA, previously found, for
example, in Staphylococcus aureus and coagulase-negative
staphylococci. Our finding provides the first sequence of an
erm gene other than ermAM that mediates
MLSB resistance in S. pyogenes.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A Novel Erythromycin Resistance Methylase Gene
(ermTR) in Streptococcus pyogenes
*
Corresponding author. Mailing address: Antimicrobial
Research Laboratory, National Public Health Institute, Kiinamyllynkatu 13, 20520 Turku, Finland. Phone: 358-2-2519255. Fax: 358-2-2519254. E-mail: helena.seppala{at}utu.fi.
Antimicrobial Agents and Chemotherapy, February 1998, p. 257-262, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |